Cannabinoid system plays a pivotal role in the seizure threshold modulation which is mainly mediated through activation of the cannabinoid CB₁ receptor. There is also several evidence of interaction between cannabinoid system and α₂-adrenoceptors in different paradigms. Using model of clonic seizure induced by intravenous pentylenetetrazole (PTZ) in male mice, we investigated whether α₂-adrenoceptors is involved in the effects of cannabinoids on the seizure threshold. Injection of the selective cannabinoid CB₁ agonist ACEA (2mg/kg) significantly (P<0.01) increased the seizure threshold which was prevented by pretreatment with the selective CB₁ antagonist AM251 (1mg/kg, i.p.). The highest doses of clonidine, a α₂ receptor agonist, (1 and 5mg/kg) showed anticonvulsant effects while yohimbine, a α₂ receptor antagonist, (0.01, 0.1, 1, and 10mg/kg) did not induce any significant effect on PTZ seizure threshold. Pretreatment with clonidine (0.1 and 0.5mg/kg) significantly reversed the anticonvulsant effect of ACEA (2mg/kg). Yohimbine (0.1, 1, and 10mg/kg) pretreatment of mice enhanced the clonic seizure threshold of ACEA (1mg/kg), significantly. Combination of non-effective doses of AM251 (0.1mg/kg) and clonidine (0.01mg/kg) showed additive effect in blocking the anticonvulsant effect of ACEA (2mg/kg). In conclusion, our findings demonstrated that α₂-adrenoceptors could be involved in the anticonvulsant properties of the specific cannabinoid CB₁ agonist ACEA, suggesting that CB₁ cannabinoid and α₂ receptors have functional interactions in modulation of clonic seizure threshold.
Copyright © 2013. Published by Elsevier B.V.